• The Latest Updated Products
  • Home > Product Partnering > The Latest Updated Products
Basic Search Search

Displaying 1 of 32 results per page Prev Next

The Latest Updated Products 게시물 리스트
product_code originator Lab Code or BRAND NAME API Action mechanism Indication Latest development stage Details
 PP090602001073   ARYx Therapeutics   ATI-7505   naronapride   A serotoni..   Gastropare..   Phase II completed, Phase II completed, Phase II    View Details 
 PP090729001202   AstraZeneca   Fasenra, MEDI-563   benralizumab   An anti-IL..   Severe ast..   Approved, Approved, Approved, Phase II    View Details 
 PP090709005573   Nymox Corporation   NX-1207, REC 0482   fexapotide triflutate   Targeting ..   Benign pro..   Phase III completed, Phase II completed    View Details 
 PP090709005621   Oncolys BioPharma Inc.   Telomelysin, OBP-301   suratadenoturev   A cancer c..   Esophageal..   NDA, Phase II, Phase II, Phase I    View Details 
 PP090709005622   Oncolys BioPharma Inc.   OBP-401, TelomeScan®(Telomelysin-GFP).      Detection ..   Detection ..   Phase III completed    View Details 
 PP090709005624   Oncolys BioPharma Inc.   Festinavir®, OBP-601, TPN-101   censavudine   A nucleoti..   Human immu..   Phase II completed, Phase II, Phase II, Phase II    View Details 
 PP090110005627   Oncolytics Biotech Inc.   Reolysin   human reovirus, pelareorep      Metastatic..   Phase II, Phase II, Phase II    View Details 
 PP101122005639   OncoTherapy Science Inc.   OTSGC-A24         Gastric ca..   Phase I    View Details 
 PP090511005791   Oncotelic Inc. (since Apr 2019), Mateon Therapeutics, Inc., OXiGENE, Inc.   Zybrestat   fosbretabulin; combretastatin A4 phosphate (CA4P)   A vascular..   Melanoma, ..   Phase I, Phase III, Phase II, Phase II    View Details 
 PP090511005792   Oncotelic (since Apr 2019), Mateon Therapeutics, Inc., OXiGENE, Inc.   OXi4503   combretastatin A1 di-phosphate (CA1P)   A dual-mec..   Refractory..   Phase I, Phase I    View Details